| Firm | Analyst |
|---|---|
| Hapoalim Securities | Raghuram Selvaraju, Ph.D. |
| Jefferies & Company, Inc. | Adam Walsh, M.D. |
| Leerink Swann and Company | Joshua Schimmer, M.D. |
| Morningstar | Brian Laegeler, CPA |
| Oppenheimer World Markets | Bret Holley, Ph.D. |
| Wedbush Pacific Growth Life Sciences | Duane Nash, MD, JD, MBA |
ARYx Therapeutics is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding ARYx Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ARYx Therapeutics or its management. ARYx Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
